FDA Inspection 730999 — Biomat USA Inc.

Biomat USA Inc. — FEI 1470275

The FDA completed an inspection of Biomat USA Inc. on Jun 21, 2011 in Chicago, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 21, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Chicago, IL (United States)

Citations

IDCFRDescription
21821 CFR 640.3(c)(2)History of viral hepatitis - close contact
923621 CFR 630.40(b)(1)Deferred or not eligible
925621 CFR 610.41Donor Deferral